EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.14.14.73 | albendazole monooxygenase (sulfoxide-forming) deficiency |
24058654 |
Inducible CYP2J2 and Its Product 11,12-EET Promotes Bacterial Phagocytosis: A Role for CYP2J2 Deficiency in the Pathogenesis of Crohn's Disease? |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
3
0 |
| 1.14.14.73 | Alzheimer Disease |
25796175 |
CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population. |
unassigned |
0 |
| 1.14.14.73 | Alzheimer Disease |
27396818 |
Gene- gene interaction between CYP2J2 and PPAR -? gene on late-onset Alzheimer's disease in the eastern Chinese Han population. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
2
1
0 |
| 1.14.14.73 | Aortic Aneurysm, Abdominal |
23446230 |
CYP2J2 Overexpression Increases EETs and Protects against Angiotensin II-Induced Abdominal Aortic Aneurysm in Mice. |
therapeutic application
unassigned |
1
0 |
| 1.14.14.73 | Arrhythmias, Cardiac |
24023684 |
CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 1.14.14.73 | Asthma |
17475630 |
Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
2 |
| 1.14.14.73 | Atherosclerosis |
17429317 |
CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
2
1 |
| 1.14.14.73 | Atherosclerosis |
26859195 |
CYP2J2 Overexpression Increases EETs and Protects Against HFD-induced Atherosclerosis in ApoE-/- Mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
1
0 |
| 1.14.14.73 | Atherosclerosis |
28000856 |
CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation. |
ongoing research
unassigned |
4
0 |
| 1.14.14.73 | Brain Infarction |
23041291 |
Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
2
4
0 |
